参考文献/References:
[1] Siegel RL,Miller KD,Fuchs HE,et al.Cancer statistics,2021[J].CA Cancer J Clin,2021,71(1):7-33.
[2] 刘军兰.乳腺癌首次成为全球最常见的癌症[J].中华乳腺病杂志:电子版,2020,14(6):389.
[3] 郑 超,苏 娟,盛杰鑫,等.乳腺癌患者病灶血流时间-信号强度曲线类型、表观弥散系数与化疗疗效相关性分析[J].陕西医学杂志,2021,50(12):1521-1524.
[4] Ahmadiankia N,Moghaddam HK,Mishan MA,et al.Berberine suppresses migration of MCF-7 breast cancer cells through down-regulation of chemokine receptors[J].Iran J Basic Med Sci,2016,19(2):125-131.
[5] Hecht SS.Inhibition of carcinogenesis by isothiocyanates[J].Drug Metab Rev,2000,32(3):395-411.
[6] Qazi A,Pal J,Maitah M,et al.Anticancer activity of a broccoli derivative,sulforaphane,in barrett adenocarcinoma:Potential use in chemoprevention and as adjuvant in chemotherapy[J].Transl Oncol,2010,3(6):389-399.
[7] 梁 欢,征宗梅,杨学攀,等.维生素D对乳腺癌细胞及乳腺癌干细胞凋亡的影响[J].现代肿瘤医学,2020,28(6):877-882.
[8] Trowbridge R,Sharma P,Hunter WJ,et al.Vitamin D receptor expression and neoadjuvant therapy in esophageal adenocarcinoma[J].Exp Mol Pathol,2012,93(1):147-153.
[9] Bagheri M,Fazli M,Saeednia S,et al.Sulforaphane modulates cell migration and expression of β-catenin and epithelial mesenchymal transition markers in breast cancer cells[J].Iran J Public Health,2020,49(1):77-85.
[10] 沙昱彤,黄家明,卢珍萍,等.维生素D调控Wnt/β-catenin信号通路抑制乳腺癌干细胞活性[J].中国癌症防治杂志,2019,11(4):297-302.
[11] 张 贺,姜大庆.鸦胆子素D对乳腺癌MDA-MB-231细胞增殖与凋亡及细胞周期的影响[J].陕西中医,2019,40(11):1495-1497.
[12] Khan A,Aljarbou AN,Aldebasi YH,et al.Resveratrol suppresses the proliferation of breast cancer cells by inhibiting fatty acid synthase signaling pathway[J].Cancer Epidemiol,2014,38(6):765-772.
[13] Reuben SC,Gopalan A,Petit DM,et al.Modulation of angiogenesis by dietary phytoconstituents in the prevention and intervention of breast cancer[J].Mol Nutr Food Res,2012,56(1):14-29.
[14] Appari M,Babu KR,Kaczorowski A,et al.Sulforaphane,quercetin and catechins complement each other in elimination of advanced pancreatic cancer by miR-let-7 induction and K-ras inhibition[J].Int J Oncol,2014,45(4):1391-1400.
[15] Gasparello J,Gambari L,Papi C,et al.High levels of apoptosis are induced in the human colon cancer HT-29 cell line by co-administration of sulforaphane and a peptide nucleic acid targeting miR-15b-5p[J].Nucleic Acid Ther,2020,30(3):164-174.
[16] Royston KJ,Paul B,Nozell S,et al.Withaferin A and sulforaphane regulate breast cancer cell cycle progression through epigenetic mechanisms[J].Exp Cell Res,2018,368(1):67-74.
[17] Lubecka-Pietruszewska K,Kaufman-Szymczyk A,Stefanska B,et al.Sulforaphane alone and in combination with clofarabine epigenetically regulates the expression of DNA methylation-silenced tumour suppressor genes in human breast cancer cells[J].J Nutrigenet Nutrigenomics,2015,8(2):91-101.
[18] Kaczyńska A,Swierczyńska J,Herman-Antosiewicz A.Sensitization of HER2 positive breast cancer cells to lapatinib using plants-derived isothiocyanates[J].Nutr Cancer,2015,67(6):976-986.
[19] Yang L,Palliyaguru DL,Kensler TW.Frugal chemoprevention:Targeting Nrf2 with foods rich in sulforaphane[J].Semin Oncol,2016,43(1):146-153.
[20] Li Y,Zhang T,Korkaya H,et al.Sulforaphane,a dietary component of broccoli/broccoli sprouts,inhibits breast cancer stem cells[J].Clin Cancer Res,2010,16(9):2580-2590.
[21] Kanematsu S,Yoshizawa K,Uehara N,et al.Sulforaphane inhibits the growth of KPL-1 human breast cancer cells in vitro and suppresses the growth and metastasis of orthotopically transplanted KPL-1 cells in female athymic mice[J].Oncol Rep,2011,26(3):603-608.
[22] Welsh J.Cellular and molecular effects of vitamin D on carcinogenesis[J].Arch Biochem Biophys,2012,523(1):107-114.
[23] 段 钊,韩红芳,王 颖.血清维生素D浓度与子宫内膜癌相关性研究[J].陕西医学杂志,2016,45(8):960-961.
[24] 郑 舒,何 津,单延红.逍遥散联合维生素D对产后抑郁大鼠行为学及脑组织形态学的影响[J].陕西中医,2021,42(10):1333-1337.
相似文献/References:
[1]乔亚舜,吴瑛琦.乳腔镜腋窝淋巴结清扫术治疗早期乳腺癌临床研究[J].陕西医学杂志,2019,(4):473.
QIAO Yashun,WU Yingqi..Clinical study of mammoscopic axillary lymph node dissection for early breast cancer patients[J].,2019,(8):473.
[2]谭兴利,陆伟辉,汤学文,等.乳腺癌患者超声检查中PSV、RI值与术后组织中MMP11、VEGF表达的相关性探讨[J].陕西医学杂志,2019,(5):617.
[3]韩丕华,宋张骏△,杨晓民,等.乳腺超声造影联合细针穿刺定位活检在判定乳腺癌新辅助化疗后腋窝淋巴结性质中的临床研究*[J].陕西医学杂志,2019,(7):842.
HAN Pihua,SONG Zhangjun,YANG Xiaomin,et al.Application of breast contrast-enhanced ultrasonography combined with fine needle aspiration biopsy in determining the axillary lymph node properties after neoadjuvant chemotherapy for breast cancer[J].,2019,(8):842.
[4]蒋 敢,王 军,王会东△.舒芬太尼联合罗哌卡因肋间神经阻滞对乳腺癌患者术后镇痛、免疫功能及应激反应的影响*[J].陕西医学杂志,2019,(8):1077.
JIANG Gan,WANG Jun,WANG Huidong..Effect of sufentanil plus ropivacaine intercostal nerve block on postoperative analgesia, immunity and stress response in patients with breast cancer[J].,2019,(8):1077.
[5]王群拴,黎小花△.核磁共振结合血清肿瘤标志物及细胞因子检测在〖JZ〗乳腺癌诊断中的应用价值研究*[J].陕西医学杂志,2019,(10):1295.
[6]韩丕华,袁 权△.乳腺癌患者白细胞介素-22表达水平对新辅助化疗后病理学完全缓解的预测价值*[J].陕西医学杂志,2020,49(7):889.[doi:DOI:10.3969/j.issn.10007377.2020.07.033]
HAN Pihua,YUAN Quan..Predictive value of IL-22 expression level in breast cancer patients for pathological complete remission after neoadjuvant chemotherapy[J].,2020,49(8):889.[doi:DOI:10.3969/j.issn.10007377.2020.07.033]
[7]韩金怡,苏志勇.21基因检测对早期Luminal A型乳腺癌治疗指导作用研究[J].陕西医学杂志,2021,50(9):1081.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.010]
HAN Jinyi,SU Zhiyong.Guiding role of 21-gene detection in treatment of early Luminal type A breast cancer[J].,2021,50(8):1081.[doi:DOI:10.3969/j.issn.1000-7377.2021.09.010]
[8]白玲娇,陈小军,王 婷.乳腺癌超声弹性成像评分与免疫组化指标表达水平相关性分析[J].陕西医学杂志,2021,50(10):1239.[doi:DOI:10.3969/j.issn.1000-7377.2021.10.015]
[9]郑 超,苏 娟,盛杰鑫,等.乳腺癌患者病灶血流时间-信号强度曲线类型、表观弥散系数与化疗疗效相关性分析[J].陕西医学杂志,2021,50(12):1521.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.013]
ZHENG Chao,SU Juan,SHENG Jiexin,et al.Correlation between focal blood flow time-signal intensity curve type,apparent diffusion coefficient and chemotherapy efficacy in breast cancer patients[J].,2021,50(8):1521.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.013]
[10]杜 森,赵 森,周 青,等.血清长链非编码RNA小核仁RNA宿主基因3检测联合核磁共振弥散加权成像在乳腺癌诊断中的应用[J].陕西医学杂志,2022,51(8):1021.[doi:DOI:10.3969/j.issn.1000-7377.2022.08.027]
DU Sen,ZHAO Sen,ZHOU Qing,et al.Value of serum lncRNA SNHG3 detectioncombined with MRI diffusion-weighted imaging in diagnosis of breast cancer[J].,2022,51(8):1021.[doi:DOI:10.3969/j.issn.1000-7377.2022.08.027]